Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1024

1.

Potential use of routine databases in health technology assessment.

Raftery J, Roderick P, Stevens A.

Health Technol Assess. 2005 May;9(20):1-92, iii-iv. Review.

2.

The measurement and monitoring of surgical adverse events.

Bruce J, Russell EM, Mollison J, Krukowski ZH.

Health Technol Assess. 2001;5(22):1-194. Review.

3.

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.

4.
5.

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ.

Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Review.

6.

Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.

Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S, Papaioannou D, Shippam A.

Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250. Review.

7.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

8.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

9.

Identification and assessment of ongoing trials in health technology assessment reviews.

Song FJ, Fry-Smith A, Davenport C, Bayliss S, Adi Y, Wilson JS, Hyde C.

Health Technol Assess. 2004 Nov;8(44):iii, 1-87. Review.

10.

An assessment of the impact of the NHS Health Technology Assessment Programme.

Hanney S, Buxton M, Green C, Coulson D, Raftery J.

Health Technol Assess. 2007 Dec;11(53):iii-iv, ix-xi, 1-180. Review.

11.

Are adverse effects incorporated in economic models? An initial review of current practice.

Craig D, McDaid C, Fonseca T, Stock C, Duffy S, Woolacott N.

Health Technol Assess. 2009 Dec;13(62):1-71, 97-181, iii. doi: 10.3310/hta13620. Review.

12.

Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.

Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.

Health Technol Assess. 2005 Jul;9(27):iii-iv, ix-xi, 1-158. Review.

13.

Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment.

Williams JG, Cheung WY, Cohen DR, Hutchings HA, Longo MF, Russell IT.

Health Technol Assess. 2003;7(26):iii, v-x, 1-117.

14.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

15.

Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer.

Czoski-Murray C, Karnon J, Jones R, Smith K, Kinghorn G.

Health Technol Assess. 2010 Nov;14(53):iii-iv, ix-x, 1-101. doi: 10.3310/hta14530. Review.

16.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

17.

An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales.

Roderick P, Nicholson T, Armitage A, Mehta R, Mullee M, Gerard K, Drey N, Feest T, Greenwood R, Lamping D, Townsend J.

Health Technol Assess. 2005 Jul;9(24):1-178. Review.

18.

Primary Care Research Team Assessment (PCRTA): development and evaluation.

Carter YH, Shaw S, Macfarlane F.

Occas Pap R Coll Gen Pract. 2002 Feb;(81):iii-vi, 1-72.

19.

A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.

Claxton K, Ginnelly L, Sculpher M, Philips Z, Palmer S.

Health Technol Assess. 2004 Jul;8(31):1-103, iii.

20.

Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.

Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C.

Health Technol Assess. 2005 Nov;9(44):1-152, iii-iv. Review.

Supplemental Content

Support Center